Nantahala Capital Management LLC Increases Position in COMPASS Pathways plc (NASDAQ:CMPS)

Nantahala Capital Management LLC lifted its holdings in COMPASS Pathways plc (NASDAQ:CMPS - Free Report) by 400.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,000,000 shares of the company's stock after buying an additional 800,000 shares during the period. Nantahala Capital Management LLC owned approximately 1.46% of COMPASS Pathways worth $3,780,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. China Universal Asset Management Co. Ltd. acquired a new stake in shares of COMPASS Pathways in the fourth quarter valued at approximately $41,000. Flagship Harbor Advisors LLC acquired a new position in shares of COMPASS Pathways during the 4th quarter valued at about $43,000. Wealthfront Advisers LLC purchased a new stake in shares of COMPASS Pathways in the fourth quarter valued at about $43,000. Conservest Capital Advisors Inc. increased its position in COMPASS Pathways by 28.9% during the fourth quarter. Conservest Capital Advisors Inc. now owns 13,363 shares of the company's stock worth $51,000 after purchasing an additional 3,000 shares during the last quarter. Finally, Simplify Asset Management Inc. acquired a new position in COMPASS Pathways in the 4th quarter valued at about $54,000. 46.19% of the stock is currently owned by institutional investors and hedge funds.

COMPASS Pathways Stock Up 2.2 %

Shares of NASDAQ:CMPS traded up $0.09 during trading on Friday, hitting $4.19. 630,272 shares of the company were exchanged, compared to its average volume of 795,540. The firm's 50 day moving average price is $3.33 and its 200-day moving average price is $4.14. COMPASS Pathways plc has a 12-month low of $2.49 and a 12-month high of $9.63. The company has a debt-to-equity ratio of 0.15, a current ratio of 8.91 and a quick ratio of 8.91. The stock has a market capitalization of $388.30 million, a P/E ratio of -1.90 and a beta of 2.34.

COMPASS Pathways (NASDAQ:CMPS - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.62) by ($0.01). On average, research analysts predict that COMPASS Pathways plc will post -2.33 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on CMPS shares. Cantor Fitzgerald reiterated an "overweight" rating on shares of COMPASS Pathways in a research report on Friday, March 28th. HC Wainwright reissued a "buy" rating and issued a $45.00 price target on shares of COMPASS Pathways in a research note on Tuesday, March 4th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $18.00 price objective on shares of COMPASS Pathways in a research report on Wednesday, January 15th. Stifel Nicolaus assumed coverage on COMPASS Pathways in a research report on Thursday, February 27th. They issued a "buy" rating and a $11.00 target price on the stock. Finally, Canaccord Genuity Group lowered their price target on COMPASS Pathways from $23.00 to $15.00 and set a "buy" rating for the company in a research report on Friday, February 28th. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, COMPASS Pathways presently has an average rating of "Buy" and a consensus price target of $20.20.

COMPASS Pathways Company Profile

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.